Genotypic resistance testing creates new treatment challenges: Two cases of oxacillin-susceptible methicillin-resistant Staphylococcus aureus

Katie A. Sharff, Stefan Monecke, Sarah Slaughter, Graeme Forrest, Chris Pfeiffer, Ralf Ehricht, Margret Oethinger

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Oxacillin-susceptible, mecA-positive Staphylococcus aureus isolates create a treatment challenge for the clinician. In this article, we describe two cases of bacteremia from isolates that carried the mecA gene but were susceptible to oxacillin (oxacillin-susceptible methicillin-resistant S. aureus [OS-MRSA]). DNA microarray analysis was used to characterize these isolates as a mecA-positive, clonal complex 5, pediatric strain and a mecA-positive, clonal complex 8, USA300 strain.

Original languageEnglish (US)
Pages (from-to)4151-4153
Number of pages3
JournalJournal of Clinical Microbiology
Volume50
Issue number12
DOIs
StatePublished - Dec 2012

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Genotypic resistance testing creates new treatment challenges: Two cases of oxacillin-susceptible methicillin-resistant Staphylococcus aureus'. Together they form a unique fingerprint.

  • Cite this